Status: Recruiting
Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke With Occlusion of the M2 Segment of Middle Cerebral Artery
RESCUE-M2O trial is a prospective, open label, blinded endpoint (PROBE), two-arm, randomized, controlled, post-market study to assess the efficacy and safety of endovascular therapy for acute ischemic stroke with occlusion of the M2 segment of the middle cerebral artery.
Participants needed: 200
Trial details
Age: 18-84Biological sex: AllType: InterventionalSponsor: Hyogo Medical UniversityUpdated: Feb 24, 2026Locations: 2
Eligibility criteria
Acute cerebral infarction [+9]
Occlusion of the anterior temporal artery, duplicate M1, or accessory M1 [+10]